Back to results
US 9,958,459 B2Granted
Application of N-terminomics to NETosis in inflammation
AssigneeBayer HealthCare LLC
InventorsYe Jin, Terry Hermiston, John Murphy
Life of this patent
Estimating the term…
Abstract
Provided herein are protein biomarkers for NETosis related diseases, including proteases. Also provided are substrate sequences of such proteases and uses thereof.
Claims11
A method for identifying a subject having a NETosis-related inflammatory condition, wherein NETosis is Neutrophil cell death forming Extracellular Traps, comprising:
- (a) determining information on NET-associated protease content from a sample from the subject, wherein the protease is selected from the group consisting of neutrophil elastase (NE), cathepsin G (CG), proteinase 3 (PR3), and neutrophil secreted protein 4 (NSP4);
- (b) comparing the level of NET-associated protease content with that of a comparable sample from a healthy subject;
- (c) identifying the subject as having a NETosis-related inflammatory condition when the level of the NET-associated protease content of the sample is greater than that of the comparable sample from the healthy subject;
- and
- (d) treating the NETosis-related inflammatory condition comprising administering to the subject a protease inhibitor, wherein the protease inhibitor inhibits cleavage of peptide substrate comprising a sequence selected from the group consisting of SEQ ID NOs. 1-180.
2 more elements
Dependencies are inferred from the claim text.